FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285681657> ?p ?o ?g. }

• W4285681657 endingPage "1512.e4" @default.
• W4285681657 startingPage "1503" @default.
• W4285681657 abstract "Background & Aims Most patients in the immunotolerant (IT) phase of chronic hepatitis B (CHB) transition to the immune active (IA-hepatitis B surface antigen [HBeAg]+) phase by early adulthood. We examined characteristics of adults in the IT vs IA-HBeAg+ phase and rate of transition from IT to other phases of CHB, with a focus on those ≥40 years. Methods Demographic, clinical, and virologic characteristics of participants in the Hepatitis B Research Network adult cohort study with IT CHB (alanine aminotransferase ≤1.5 × upper limit of normal, hepatitis B virus DNA >107 IU/mL) were compared by age category, and to those with IA-HBeAg+ CHB in cross-sectional analysis. This study received institutional review board approval at all participating centers. Results Of 107 adult IT participants, 52 (48%) were <30, 33 (31%) were 30 to 39, and 22 (21%) were ≥40 years old (maximum, 71 years). Among IT groups, the proportion born in Asia and duration of CHB were greater in older IT groups, but virologic and liver disease characteristics were similar. Compared with IA-HBeAg+ participants (n = 192), IT participants were younger, fewer were men, more were Asian, and platelets, qHBsAg, and qHBeAg levels were higher. Similar differences were observed when comparisons were made with the ≥40 years IT group. Among IT participants, 60 (56%) transitioned during 206 person-years of follow-up. The phase transition rate per 100 person-years was highest in the <30 years group (33.0 [95% confidence interval [CI], 23.4-46.7]) vs the 30 to 39 years group (24.8 [95% CI, 15.6-39.4]) and ≥40 group (27.4 [95% CI, 14.8-50.9]), but 95% CIs overlapped. Conclusions In a large North American population, over 50% of adults in the IT phase of CHB were ≥30 years and 20% were ≥40 years old, but older IT patients had similar characteristics and rates of transition as younger IT patients. Most patients in the immunotolerant (IT) phase of chronic hepatitis B (CHB) transition to the immune active (IA-hepatitis B surface antigen [HBeAg]+) phase by early adulthood. We examined characteristics of adults in the IT vs IA-HBeAg+ phase and rate of transition from IT to other phases of CHB, with a focus on those ≥40 years. Demographic, clinical, and virologic characteristics of participants in the Hepatitis B Research Network adult cohort study with IT CHB (alanine aminotransferase ≤1.5 × upper limit of normal, hepatitis B virus DNA >107 IU/mL) were compared by age category, and to those with IA-HBeAg+ CHB in cross-sectional analysis. This study received institutional review board approval at all participating centers. Of 107 adult IT participants, 52 (48%) were <30, 33 (31%) were 30 to 39, and 22 (21%) were ≥40 years old (maximum, 71 years). Among IT groups, the proportion born in Asia and duration of CHB were greater in older IT groups, but virologic and liver disease characteristics were similar. Compared with IA-HBeAg+ participants (n = 192), IT participants were younger, fewer were men, more were Asian, and platelets, qHBsAg, and qHBeAg levels were higher. Similar differences were observed when comparisons were made with the ≥40 years IT group. Among IT participants, 60 (56%) transitioned during 206 person-years of follow-up. The phase transition rate per 100 person-years was highest in the <30 years group (33.0 [95% confidence interval [CI], 23.4-46.7]) vs the 30 to 39 years group (24.8 [95% CI, 15.6-39.4]) and ≥40 group (27.4 [95% CI, 14.8-50.9]), but 95% CIs overlapped. In a large North American population, over 50% of adults in the IT phase of CHB were ≥30 years and 20% were ≥40 years old, but older IT patients had similar characteristics and rates of transition as younger IT patients." @default.
• W4285681657 created "2022-07-17" @default.
• W4285681657 creator A5013138122 @default.
• W4285681657 creator A5019470247 @default.
• W4285681657 creator A5019626103 @default.
• W4285681657 creator A5024385881 @default.
• W4285681657 creator A5043626370 @default.
• W4285681657 creator A5049864482 @default.
• W4285681657 creator A5050592436 @default.
• W4285681657 creator A5065585185 @default.
• W4285681657 creator A5077140895 @default.
• W4285681657 creator A5083390910 @default.
• W4285681657 date "2023-06-01" @default.
• W4285681657 modified "2023-10-17" @default.
• W4285681657 title "Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection" @default.
• W4285681657 cites W1593662142 @default.
• W4285681657 cites W1980507733 @default.
• W4285681657 cites W1983857472 @default.
• W4285681657 cites W2064621848 @default.
• W4285681657 cites W2104389844 @default.
• W4285681657 cites W2139876331 @default.
• W4285681657 cites W2146353434 @default.
• W4285681657 cites W2165984116 @default.
• W4285681657 cites W2174723704 @default.
• W4285681657 cites W2267571233 @default.
• W4285681657 cites W2560241854 @default.
• W4285681657 cites W2605785536 @default.
• W4285681657 cites W2766366395 @default.
• W4285681657 cites W2775503072 @default.
• W4285681657 cites W2791839818 @default.
• W4285681657 cites W2896700797 @default.
• W4285681657 cites W2905371854 @default.
• W4285681657 cites W2917618522 @default.
• W4285681657 cites W3022063648 @default.
• W4285681657 cites W3031400548 @default.
• W4285681657 cites W3046449061 @default.
• W4285681657 cites W3081683563 @default.
• W4285681657 cites W3085639123 @default.
• W4285681657 cites W3133488458 @default.
• W4285681657 cites W3165676370 @default.
• W4285681657 doi "https://doi.org/10.1016/j.cgh.2022.06.015" @default.
• W4285681657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35843468" @default.
• W4285681657 hasPublicationYear "2023" @default.
• W4285681657 type Work @default.
• W4285681657 citedByCount "3" @default.
• W4285681657 countsByYear W42856816572023 @default.
• W4285681657 crossrefType "journal-article" @default.
• W4285681657 hasAuthorship W4285681657A5013138122 @default.
• W4285681657 hasAuthorship W4285681657A5019470247 @default.
• W4285681657 hasAuthorship W4285681657A5019626103 @default.
• W4285681657 hasAuthorship W4285681657A5024385881 @default.
• W4285681657 hasAuthorship W4285681657A5043626370 @default.
• W4285681657 hasAuthorship W4285681657A5049864482 @default.
• W4285681657 hasAuthorship W4285681657A5050592436 @default.
• W4285681657 hasAuthorship W4285681657A5065585185 @default.
• W4285681657 hasAuthorship W4285681657A5077140895 @default.
• W4285681657 hasAuthorship W4285681657A5083390910 @default.
• W4285681657 hasConcept C126322002 @default.
• W4285681657 hasConcept C203014093 @default.
• W4285681657 hasConcept C205545832 @default.
• W4285681657 hasConcept C2522874641 @default.
• W4285681657 hasConcept C2775940106 @default.
• W4285681657 hasConcept C2777075537 @default.
• W4285681657 hasConcept C2777382497 @default.
• W4285681657 hasConcept C2777410769 @default.
• W4285681657 hasConcept C2780593183 @default.
• W4285681657 hasConcept C3020491458 @default.
• W4285681657 hasConcept C44249647 @default.
• W4285681657 hasConcept C71924100 @default.
• W4285681657 hasConcept C72563966 @default.
• W4285681657 hasConcept C90924648 @default.
• W4285681657 hasConceptScore W4285681657C126322002 @default.
• W4285681657 hasConceptScore W4285681657C203014093 @default.
• W4285681657 hasConceptScore W4285681657C205545832 @default.
• W4285681657 hasConceptScore W4285681657C2522874641 @default.
• W4285681657 hasConceptScore W4285681657C2775940106 @default.
• W4285681657 hasConceptScore W4285681657C2777075537 @default.
• W4285681657 hasConceptScore W4285681657C2777382497 @default.
• W4285681657 hasConceptScore W4285681657C2777410769 @default.
• W4285681657 hasConceptScore W4285681657C2780593183 @default.
• W4285681657 hasConceptScore W4285681657C3020491458 @default.
• W4285681657 hasConceptScore W4285681657C44249647 @default.
• W4285681657 hasConceptScore W4285681657C71924100 @default.
• W4285681657 hasConceptScore W4285681657C72563966 @default.
• W4285681657 hasConceptScore W4285681657C90924648 @default.
• W4285681657 hasIssue "6" @default.
• W4285681657 hasLocation W42856816571 @default.
• W4285681657 hasLocation W42856816572 @default.
• W4285681657 hasOpenAccess W4285681657 @default.
• W4285681657 hasPrimaryLocation W42856816571 @default.
• W4285681657 hasRelatedWork W2031291226 @default.
• W4285681657 hasRelatedWork W2049144368 @default.
• W4285681657 hasRelatedWork W2091706522 @default.
• W4285681657 hasRelatedWork W2359768808 @default.
• W4285681657 hasRelatedWork W2377909279 @default.
• W4285681657 hasRelatedWork W2392323650 @default.
• W4285681657 hasRelatedWork W2405118428 @default.
• W4285681657 hasRelatedWork W2418634748 @default.

• next